Related Experiment Video
Updated: Oct 1, 2025
07:04
Optimization of In vitro Transcription Reaction for mRNA Production Using Chromatographic At-Line Monitoring
Published on: April 4, 2025
1.2K
Current Status and Future Perspectives on MRNA Drug Manufacturing.
Cameron Webb1, Shell Ip2, Nuthan V Bathula3
1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, United Kingdom.
Molecular Pharmaceutics
|March 3, 2022
Summary
The rapid development of messenger RNA (mRNA) vaccines against COVID-19 highlights the modularity of mRNA and lipid nanoparticle (LNP) technologies. This adaptability promises a future of diverse RNA medicines, but manufacturing capacity must expand to meet rising demand.
Area of Science:
- Biotechnology
- Vaccinology
- Pharmaceutical Sciences
Background:
- The COVID-19 pandemic accelerated the development and approval of the first messenger RNA (mRNA) vaccines against SARS-CoV-2.
- mRNA vaccine technology demonstrated remarkable speed due to its modular nature and existing research in mRNA therapeutics.
- Lipid nanoparticle (LNP) delivery systems are also modular, facilitating rapid adaptation for new targets.
Purpose of the Study:
- To review the trends and intensification of research and development in RNA medicines.
- To analyze the manufacturing demands and capacities for mRNA drug substance (DS) and LNP drug product (DP).
- To explore future manufacturing technologies and strategies for RNA medicines.
Main Methods:
- Analysis of publication records and clinical trial registrations to track RNA medicine research.
- Examination of dosing requirements for approved mRNA vaccines to estimate manufacturing demand.
- Review of current mRNA-LNP production methods, technologies, and global manufacturing capacities.
Main Results:
- Significant increase in preclinical and clinical research for RNA-based therapeutics.
- Existing manufacturing capacity for mRNA and LNP is strained, leading to vaccine shortages.
- Analysis indicates future RNA medicines will further strain manufacturing resources.
Conclusions:
- The modularity of mRNA and LNP technologies enables rapid development of new RNA medicines for various diseases, including cancer and gene therapy.
- Addressing manufacturing bottlenecks and scaling production are critical for the widespread adoption of RNA medicines.
- Emerging technologies like self-amplifying mRNA and microfluidic production will be key to the RNA medicine revolution.
Related Concept Videos
02:24Ribosome Profiling
3.7K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.7K
02:51mRNA Stability and Gene Expression
3.0K
3.0K
02:22Regulated mRNA Transport
6.5K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.5K
01:29Microorganisms in Medicine and Therapeutics
441
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
441
02:24Regulation of Expression Occurs at Multiple Steps
23.6K
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
23.6K
01:56Riboswitches
8.7K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.7K